Results 71 to 80 of about 18,647 (241)
Bullous pemphigoid evolving into cicatricial pemphigoid?
, 1997 We describe three patients who initially presented with both clinical and immunological findings to support a diagnosis of bullous pemphigoid but whose subsequent course has been that of cicatricial pemphigoid.
Papadavid, E +5 more
core +1 more source
Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors
Journal of Cutaneous Pathology, EarlyView.ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He +11 more
wiley +1 more source
Journal of Cutaneous Pathology, EarlyView.ABSTRACT Background Lichenoid and granulomatous stomatitis (LGS) is a rare condition, with clinicopathological features resembling lichenoid and granulomatous dermatitis. Despite increasing reports, its etiology remains unclear and detailed immunohistochemical (IHC) studies are lacking.
Mariana Paravani Palaçon +12 more
wiley +1 more source
Pemphigoid gestationis: clinical and laboratory evaluation
Clinics, 2009 INTRODUCTION: Pemphigoid gestationis, also known as herpes gestationis, is a rare autoimmune blistering disease associated with pregnancy. It usually occurs during the second or third trimester, but it may be present at any stage of pregnancy or the ...
Marina Flangini Cobo +3 more
doaj +1 more source
Effect and length of doxycycline administration in elderly patients with bullous pemphigoid
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease and primarily affects the elderly. Systemic corticosteroids and immunosuppressive drugs are the standard treatment, but side effects often restrict their use. Doxycycline has been proposed as an alternative, but there is limited long‐term, real‐world data on its
Alena Merkel‐Ropele +2 more
wiley +1 more source
Pruritus with pemphigoid autoantibodies is the tip of an iceberg.
, 2019 To the Editor: I read with interest the recent study in which Lamberts et al1 describe the clinical features and disease course of a cohort of patients with nonbullous pemphigoid (NBP).
Byth, Lachlan A
core +1 more source
Pemphigoid and ulcerative colitis.
, 1988 We report eight patients with ulcerative colitis who have subsequently developed pemphigoid. Four patients were investigated to determine the pattern of pemphigoid antibody staining on whole and chemically split skin and oral mucosa to distinguish ...
Barth, JH +6 more
core +1 more source
Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis
International Journal of Dermatology, EarlyView.Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller +11 more
wiley +1 more source
Development of Nummular Dermatitis Following Dupilumab Therapy Suggests a Th17‐Driven Mechanism
Australasian Journal of Dermatology, EarlyView.
Olga Pawlik, Michelle McRae
wiley +1 more source
Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection
Immunology &Cell Biology, EarlyView.Impact of S. aureus epicutaneous sensitization models on mast cell function in vivo. D. farinae and Staphylococcal enterotoxin B (SEB) activate Trpv1+ Tac1+ nociceptors to trigger the release of substance P (SP), which promotes mast cell degranulation through Mrgprb2. S.
Hannah Dychtenberg +3 more
wiley +1 more source